Study: MuGard eases oral mucositis symptoms
MuGard has been shown to reduce mouth and throat soreness associated with oral mucositis, according to a poster presented by Access Pharmaceuticals at the American Society for Radiation Oncology meeting in Atlanta this week. The poster presentation discussed the findings from the company’s postmarketing clinical trial, which evaluated the efficacy of MuGard in controlling symptoms caused by mucositis in 120 patients receiving chemoradiation therapy for the treatment of cancers of

